6 Several of these drugs, such as Wegovy and Zepbound, were approved for use as a treatment for obesity, obstructive sleep apnea, heart attack or stroke prevention in those who have already experienced a cardiovascular event
Memberi sinyal ke otak untuk menekan rasa lapar, sehingga kamu bisa lebih mudah mengontrol nafsu makan
Physiology of GLP-1 Clinical effects of GLP-1r agonists and DPP-4 inhibitors stemming from incretin action
By treating both liver disease and its metabolic causes, semaglutide offers a promising new approach for millions of patients. The clinical trial involved participants with moderate to advanced liver scarring who were treated for 72 weeks with either a 2.4-milligram weekly injection of semaglutide or a placebo
scientific advisory board membership of Esperion Therapeutics, Preciseli, TenSixteen Bio and Tourmaline Bio